$12.75M Securities Settlement Against Cancer Drug Maker Gains Initial Approval
SAN DIEGO — A federal judge in California on Jan. 11 granted preliminary approval of a $12.75 million settlement in a class action against a pharmaceutical company and certain of its...To view the full article, register now.
Already a subscriber? Click here to view full article